L. Ridnour

发表

Ets-1 is a transcriptional mediator of oncogenic nitric oxide signaling in estrogen receptor-negative breast cancer

S. Ambs, D. Wink, C. Switzer, 2012, Breast Cancer Research.

Design, synthesis and biological evaluation of hybrid nitroxide-based non-steroidal anti-inflammatory drugs.

R. Jensen, T. Moody, D. Wink, 2018, European journal of medicinal chemistry.

Understanding the tumour micro‐environment communication network from an NOS2/COX2 perspective

S. Lockett, D. Wink, S. Anderson, 2018, British journal of pharmacology.

Thrombospondin 1 and vasoactive agents indirectly alter tumor blood flow.

D. Wink, L. Ridnour, D. Roberts, 2008, Neoplasia.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Manish R. Patel, Charles J. Vaske, Joe Y. Chang, 2016, Journal for Immunotherapy of Cancer.

Role of nitric oxide in pancreatic cancer cells exhibiting the invasive phenotype

D. Wink, R. Cheng, L. Ridnour, 2019, Redox Biology.

CD47 Receptor Globally Regulates Metabolic Pathways That Control Resistance to Ionizing Radiation*

D. Wink, W. Degraff, L. Ridnour, 2015, The Journal of Biological Chemistry.

Nitric oxide and protein phosphatase 2 A provide novel therapeutic opportunities in ER-negative breast cancer

S. Ambs, D. Wink, M. Vitek, 2012 .

Nitric oxide and protein phosphatase 2A provide novel therapeutic opportunities in ER-negative breast cancer.

S. Ambs, D. Wink, M. Vitek, 2011, Trends in pharmacological sciences.

Radioprotection in Normal Tissue and Delayed Tumor Growth by Blockade of CD47 Signaling

D. Wink, W. Degraff, L. Ridnour, 2009, Science Translational Medicine.

HNO Protects the Myocardium against Reperfusion Injury, Inhibiting the mPTP Opening via PKCε Activation

D. Wink, S. Sollott, L. Ridnour, 2022, Antioxidants.

Dithiolethione modified valproate and diclofenac increase E-cadherin expression and decrease proliferation of non-small cell lung cancer cells.

G. Giaccone, R. Jensen, T. Moody, 2010, Lung cancer.

Asbestos redirects nitric oxide signaling through rapid catalytic conversion to nitrite.

D. Wink, L. Ridnour, D. Pociask, 2006, Cancer research.

Molecular Mechanisms of Nitric Oxide in Cancer Progression, Signal Transduction, and Metabolism.

D. Wink, S. Anderson, R. Cheng, 2019, Antioxidants & redox signaling.

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model.

D. Wink, R. Cheng, L. Ridnour, 2020, Journal of visualized experiments : JoVE.

Nitric Oxide Synthase and Breast Cancer: Role of TIMP-1 in NO-mediated Akt Activation

S. Ambs, D. Wink, H. Yfantis, 2012, PloS one.

Macrophage-dependent nitric oxide expression regulates tumor cell detachment and metastasis after IL-2/anti-CD40 immunotherapy

J. Weiss, C. Harris, D. Wink, 2010, The Journal of experimental medicine.

A divergent mode of activation of a nitrosyl iron complex with unusual antiangiogenic activity.

D. Wink, L. Ridnour, Elisane Longhinotti, 2020, Journal of inorganic biochemistry.

Endothelin causes transactivation of the EGFR and HER2 in non-small cell lung cancer cells

R. Jensen, T. Moody, L. Ridnour, 2017, Peptides.

Nitric Oxide Synthase-2-Derived Nitric Oxide Drives Multiple Pathways of Breast Cancer Progression.

S. Ambs, D. Wink, R. Cheng, 2017, Antioxidants & redox signaling.

Pituitary adenylate cyclase activating polypeptide causes tyrosine phosphorylation of the EGF receptor in lung cancer cells

R. Jensen, T. Moody, D. Wink, 2012 .

Pituitary Adenylate Cyclase-Activating Polypeptide Causes Tyrosine Phosphorylation of the Epidermal Growth Factor Receptor in Lung Cancer Cells

R. Jensen, T. Moody, D. Wink, 2012, Journal of Pharmacology and Experimental Therapeutics.

Neuromedin B receptors regulate EGF receptor tyrosine phosphorylation in lung cancer cells.

G. Giaccone, R. Jensen, T. Moody, 2010, European Journal of Pharmacology.

Itaconic acid mediates crosstalk between macrophage metabolism and peritoneal tumors

J. Weiss, D. Wink, R. Cheng, 2018, The Journal of clinical investigation.

CD47 in the tumor microenvironment limits cooperation between antitumor T-cell immunity and radiotherapy.

J. Berzofsky, D. Wink, W. Degraff, 2014, Cancer research.

CD 47 in the tumor microenvironment limits cooperation between anti-tumor T cell immunity and radiation therapy

J. Berzofsky, D. Wink, W. Degraff, 2014 .

The activation of metabolites of nitric oxide synthase by metals is both redox and oxygen dependent: a new feature of nitrogen oxide signaling.

D. Wink, C. Switzer, L. Ridnour, 2006, Antioxidants & redox signaling.

Discriminating formation of HNO from other reactive nitrogen oxide species.

D. Wink, L. Ridnour, N. Paolocci, 2006, Free radical biology & medicine.

Nitric oxide‐mediated regulation of β ‐amyloid clearance via alterations of MMP‐9/TIMP‐1

C. Colton, D. Wilcock, D. Wink, 2012, Journal of neurochemistry.

Tumor suppressive effects of MnSOD overexpression may involve imbalance in peroxide generation versus peroxide removal.

L. Oberley, L. Ridnour, T. Oberley, 2004, Antioxidants & redox signaling.

Thrombospondin-1 and CD47 limit cell and tissue survival of radiation injury.

D. Wink, W. Degraff, L. Ridnour, 2008, The American journal of pathology.

Thrombospondin 1 promotes tumor macrophage recruitment and enhances tumor cell cytotoxicity of differentiated U937 cells.

D. Wink, L. Ridnour, D. Roberts, 2008, Cancer research.

Molecular mechanisms for discrete nitric oxide levels in cancer.

S. Ambs, D. Wink, C. Switzer, 2008, Nitric oxide : biology and chemistry.

Tumor microenvironment-based feed-forward regulation of NOS2 in breast cancer progression

S. Ambs, D. Wink, S. Hussain, 2014, Proceedings of the National Academy of Sciences.

Increased hepatic telomerase activity in a rat model of iron overload: a role for altered thiol redox state?

L. Ridnour, D. Spitz, W. Schmidt, 2007, Free radical biology & medicine.

Phenotypic changes induced in human breast cancer cells by overexpression of manganese-containing superoxide dismutase.

D. S. St. Clair, L. Oberley, J. Li, 1995, Oncogene.

Superoxide dismutase activities of differentiating clones from an immortal cell line

L. Oberley, D. Guernsey, L. Ridnour, 1989, Journal of cellular physiology.

Comprehensive characterization of heat shock protein 27 phosphorylation in human endothelial cells stimulated by the microbial dithiole thiolutin.

D. Wink, B. Karger, Shujia Dai, 2008, Journal of proteome research.

CD47 Is Necessary for Inhibition of Nitric Oxide-stimulated Vascular Cell Responses by Thrombospondin-1*

D. Wink, L. Ridnour, D. Roberts, 2006, Journal of Biological Chemistry.

Dominant-negative Jun N-terminal protein kinase (JNK-1) inhibits metabolic oxidative stress during glucose deprivation in a human breast carcinoma cell line.

H. Forman, Y. Lee, L. Ridnour, 2000, Free radical biology & medicine.

Dithiolethione Compounds Inhibit Akt Signaling in Human Breast and Lung Cancer Cells by Increasing PP2A Activity

T. Moody, A. Sparatore, D. Wink, 2009, Oncogene.

Thrombospondin-1 inhibits endothelial cell responses to nitric oxide in a cGMP-dependent manner.

D. Wink, L. Ridnour, D. Roberts, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Comparison of the NO and HNO donating properties of diazeniumdiolates: primary amine adducts release HNO in Vivo.

D. Kass, K. Houk, D. Wink, 2005, Journal of medicinal chemistry.

Thiolutin inhibits endothelial cell adhesion by perturbing Hsp27 interactions with components of the actin and intermediate filament cytoskeleton

D. Wink, B. Karger, Shujia Dai, 2010, Cell Stress and Chaperones.

The specificity of nitroxyl chemistry is unique among nitrogen oxides in biological systems.

D. Wink, C. Switzer, L. Ridnour, 2011, Antioxidants & redox signaling.

Mechanism of aerobic decomposition of Angeli's salt (sodium trioxodinitrate) at physiological pH.

K. Houk, D. Wink, L. Ridnour, 2005, Journal of the American Chemical Society.

Modulation of angiogenesis by dithiolethione‐modified NSAIDs and valproic acid

T. Moody, A. Sparatore, D. Wink, 2007, British journal of pharmacology.

The biphasic nature of nitric oxide responses in tumor biology.

D. Wink, L. Ridnour, D. Roberts, 2006, Antioxidants & redox signaling.

NOS2 and COX2 Blockade Limits TNBC Disease Progression and Alters CD8+ T Cell Spatial Orientation and Density

S. Lockett, S. Ambs, S. Hewitt, 2022, bioRxiv.

Comparison of the chemical biology of NO and HNO: An inorganic perspective

M. Ferlito, D. Citrin, D. Wink, 2005 .

Enhanced gamma-glutamyl transpeptidase expression and selective loss of CuZn superoxide dismutase in hepatic iron overload.

H. Frierson, M. Freeman, L. Oberley, 1998, Free radical biology & medicine.

Blockade of CD47 increases survival of mice exposed to lethal total body irradiation

D. Wink, L. Ridnour, D. Soto-Pantoja, 2013, Scientific Reports.

A polymerase chain reaction assay for simultaneous detection and quantitation of proto‐oncogene and GAPD mRNAs in different cell growth rates

L. Albee, L. Ridnour, D. Spitz, 1997, Cell proliferation.

Nitric Oxide Modulates Metabolic Processes in the Tumor Immune Microenvironment

S. Lockett, D. Wink, S. Anderson, 2021, International journal of molecular sciences.

S-Nitrosation Mediates Multiple Pathways That Lead to Tumor Progression in Estrogen Receptor-Negative Breast Cancer.

S. Ambs, D. Wink, C. Switzer, 2012, Forum on immunopathological diseases and therapeutics.

A spectrophotometric method for the direct detection and quantitation of nitric oxide, nitrite, and nitrate in cell culture media.

D. Wink, L. Ridnour, D. Spitz, 2000, Analytical biochemistry.

Bromination of deoxycytidine by eosinophil peroxidase: a mechanism for mutagenesis by oxidative damage of nucleotide precursors.

W. Parks, L. Ridnour, J. P. Henderson, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Synthesis and chemical and biological comparison of nitroxyl- and nitric oxide-releasing diazeniumdiolate-based aspirin derivatives.

D. Wink, Sa Shi, R. Cheng, 2013, Journal of medicinal chemistry.

The chemistry of nitrosative stress induced by nitric oxide and reactive nitrogen oxide species. Putting perspective on stressful biological situations

D. Wink, L. Ridnour, N. Paolocci, 2004, Biological chemistry.

Inducible Nitric Oxide Synthase in the Carcinogenesis of Gastrointestinal Cancers.

D. Wink, R. Cheng, L. Ridnour, 2017, Antioxidants & redox signaling.

Molecular Pathways Molecular Pathways : Toll-like Receptors in the Tumor Microenvironment — Poor Prognosis or New Therapeutic Opportunity

G. Trinchieri, S. Ambs, D. Wink, 2013 .

Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells.

P. Meltzer, J. Trent, L. Oberley, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Nitric oxide in wound‐healing

David D Roberts, D. Wink, L. Ridnour, 2005, Microsurgery.

Measurement of glutathione, glutathione disulfide, and other thiols in mammalian cell and tissue homogenates using high-performance liquid chromatography separation of N-(1-pyrenyl)maleimide derivatives.

L. Ridnour, D. Spitz, N. Ercal, 1999, Methods in enzymology.

Metalloporphyrin coordination chemistry of highly oxidizing oxyanions: the chromate complex of iron(III) tetraphenylporphyrin

L. Ridnour, H. Goff, G. Godziela, 1985 .

Nitric oxide and redox mechanisms in the immune response

C. Colton, D. Wink, M. Vitek, 2011, Journal of leukocyte biology.

Metabolic oxidative stress activates signal transduction and gene expression during glucose deprivation in human tumor cells.

Y. Lee, L. Ridnour, D. Spitz, 1999, Free radical biology & medicine.

CD47 deficiency confers cell and tissue radioprotection by activation of autophagy

D. Wink, W. Degraff, L. Ridnour, 2012, Autophagy.

Dithiolethiones inhibit NF-κB activity via covalent modification in human estrogen receptor-negative breast cancer.

S. Ambs, A. Sparatore, D. Wink, 2012, Cancer research.

The chemical biology of nitric oxide: implications in cellular signaling.

C. Harris, S. Ambs, C. Colton, 2008, Free radical biology & medicine.

Cell cycle-coupled variation in topoisomerase IIalpha mRNA is regulated by the 3'-untranslated region. Possible role of redox-sensitive protein binding in mRNA accumulation.

C. Hunt, L. Albee, R. Higashikubo, 2000, The Journal of biological chemistry.

Biological signaling by small inorganic molecules.

D. Wink, L. Ridnour, Aparna H Kesarwala, 2016, Coordination chemistry reviews.

Glucose Deprivation‐Induced Oxidative Stress in Human Tumor Cells: A Fundamental Defect in Metabolism?

L. Ridnour, D. Spitz, J. E. Sim, 2000, Annals of the New York Academy of Sciences.

Chronic Exposure to Nitric Oxide Induces P53 Mutations and Malignant-like Features in Human Breast Epithelial Cells

T. Moody, S. Ambs, D. Wink, 2023, Biomolecules.

Chapter 5 – Nitric Oxide and Redox Inflammation in Cancer

D. Wink, C. Switzer, R. Cheng, 2010 .

Macrophages, Nitric Oxide and microRNAs Are Associated with DNA Damage Response Pathway and Senescence in Inflammatory Bowel Disease

Jane J. Sohn, A. Schetter, E. Bowman, 2012, PloS one.

COX-2 activation is associated with Akt phosphorylation and poor survival in ER-negative, HER2-positive breast cancer

S. Ambs, D. Wink, R. Prueitt, 2010, BMC Cancer.

Inducible nitric oxide synthase-derived extracellular nitric oxide flux regulates proinflammatory responses at the single cell level

S. Lockett, G. Altan-Bonnet, D. Wink, 2019, Redox biology.

Increased NOS2 predicts poor survival in estrogen receptor-negative breast cancer patients.

R. Stephens, M. Yi, S. Ambs, 2010, The Journal of clinical investigation.

Systemic Nos2 Depletion and Cox inhibition limits TNBC disease progression and alters lymphoid cell spatial orientation and density

S. Ambs, S. Hewitt, D. Wink, 2022, Redox biology.

Nitric oxide regulates matrix metalloproteinase-9 activity by guanylyl-cyclase-dependent and -independent pathways

Michael P Vitek, David D Roberts, D. Wink, 2007, Proceedings of the National Academy of Sciences.

The reemergence of nitric oxide and cancer.

C. Harris, D. Wink, S. Hussain, 2008, Nitric oxide : biology and chemistry.

Ets-1 is a transcriptional mediator of oncogenic nitric oxide signaling in estrogen receptor-negative breast cancer

S. Ambs, D. Wink, C. Switzer, 2012, Breast Cancer Research.

S-Nitrosylation of EGFR and Src Activates an Oncogenic Signaling Network in Human Basal-Like Breast Cancer

S. Ambs, D. Wink, Jeffrey E. Green, 2012, Molecular Cancer Research.

Signaling and Regulation S-Nitrosylation of EGFR and Src Activates an Oncogenic Signaling Network in Human Basal-Like Breast Cancer

S. Ambs, D. Wink, Jeffrey E. Green, 2012 .

Superoxide Fluxes Limit Nitric Oxide-induced Signaling*

James B. Mitchell, C. Harris, S. Ambs, 2006, Journal of Biological Chemistry.

NOS Inhibition Modulates Immune Polarization and Improves Radiation-Induced Tumor Growth Delay.

James B. Mitchell, J. Weiss, G. Trinchieri, 2015, Cancer research.

Hypoxic inducible factor 1α, extracellular signal-regulated kinase, and p53 are regulated by distinct threshold concentrations of nitric oxide

C. Harris, D. Wink, L. Hofseth, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Nitric Oxide and Cancer: An Overview

C. Harris, S. Ambs, D. Wink, 2010 .

Nitric Oxide and Cancer: When to Give and When to Take Away?

D. Wink, L. Ridnour, K. Miranda, 2021, Inorganic chemistry.

Signaling and stress: The redox landscape in NOS2 biology.

D. Wink, C. Switzer, R. Cheng, 2015, Free radical biology & medicine.

Antisense targeting of CD47 enhances human cytotoxic T-cell activity and increases survival of mice bearing B16 melanoma when combined with anti-CTLA4 and tumor irradiation

L. Ridnour, D. Roberts, N. Restifo, 2019, Cancer Immunology, Immunotherapy.

Nitric oxide regulates angiogenesis through a functional switch involving thrombospondin-1.

D. Wink, L. Ridnour, D. Roberts, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Activation of matrix metalloproteinases following anti-Aβ immunotherapy; implications for microhemorrhage occurrence

T. L. Taylor, C. Colton, D. Wilcock, 2011, Journal of Neuroinflammation.

Determinants of Nitric Oxide Chemistry. Impact of Cell Signaling Processes.

D. Wink, C. Switzer, L. Ridnour, 2010 .

Guanylyl cyclase-dependent chemotaxis of endothelial cells in response to nitric oxide gradients.

D. Wink, L. Ridnour, D. Roberts, 2006, Free radical biology & medicine.

Evaluation of the role of reactive oxygen species in doxorubicin hydrochloride nephrosis.

L. Oberley, L. Ridnour, D. Klinzman, 1991, Journal of Laboratory and Clinical Medicine.

A Mitochondrial Target Sequence Polymorphism in Manganese Superoxide Dismutase Predicts Inferior Survival in Breast Cancer Patients Treated with Cyclophosphamide

S. Geisler, P. Lønning, A. Børresen-Dale, 2009, Clinical Cancer Research.

Orthogonal properties of the redox siblings nitroxyl and nitric oxide in the cardiovascular system: a novel redox paradigm.

D. Kass, C. Colton, D. Wink, 2003, American journal of physiology. Heart and circulatory physiology.

The Orthogonal Properties of the Redox Siblings Nitroxyl ( HNO ) and Nitric Oxide ( NO ) in the Cardiovascular System : A Novel Redox Paradigm

D. Kass, C. Colton, D. Wink, 2003 .

The impact of human and mouse differences in NOS2 gene expression on the brain’s redox and immune environment

Michael P Vitek, Carol A Colton, C. Colton, 2014, Molecular Neurodegeneration.

Autocrine IL-10 functions as a rheostat for M1 macrophage glycolytic commitment by tuning nitric oxide production☆☆☆

J. Weiss, D. Wink, S. Hussain, 2016, Redox biology.

Advances in Breast Cancer Therapy Using Nitric Oxide and Nitroxyl Donor Agents

D. Wink, L. Ridnour, K. Miranda, 2016 .

Gene expression profiles of NO- and HNO-donor treated breast cancer cells: insights into tumor response and resistance pathways.

S. Ambs, D. Wink, C. Switzer, 2014, Nitric oxide : biology and chemistry.

Bromination of deoxycytidine by eosinophil peroxidase

W. Parks, L. Ridnour, J. P. Henderson, 2001 .

Induction of MnSOD gene expression in a hepatic model of TNF-alpha toxicity does not result in increased protein.

M. Czaja, L. Oberley, L. Ridnour, 1994, The American journal of physiology.

Effect of iron overload and dietary fat on indices of oxidative stress and hepatic fibrogenesis in rats

L. Ridnour, D. Spitz, R. Kladney, 2003, Liver international : official journal of the International Association for the Study of the Liver.

Chemotherapeutic potential of diazeniumdiolate-based aspirin prodrugs in breast cancer.

D. Wink, L. Ridnour, K. Miranda, 2014, Free radical biology & medicine.

The emergence of nitroxyl (HNO) as a pharmacological agent.

D. Wink, C. Switzer, L. Ridnour, 2009, Biochimica et biophysica acta.

NO in Cancer—Carcinogenesis, Metastasis, and Therapy

D. Wink, R. Cheng, L. Ridnour, 2017 .

Nitric Oxide and Its Gatekeeper Thrombospondin-1 in Tumor Angiogenesis

D. Wink, L. Ridnour, D. Roberts, 2007, Clinical Cancer Research.

Nitric Oxide and Its Gatekeeper Thrombospondin-1 in TumorAngiogenesis

D. Wink, L. Ridnour, D. Roberts, 2007 .

Comparing the chemical biology of NO and HNO

D. Wink, C. Switzer, L. Ridnour, 2009, Archives of pharmacal research.

The impact of human and mouse differences in NOS2 gene expression on the brain’s redox and immune environment

C. Colton, D. Wink, M. Vitek, 2014, Molecular Neurodegeneration.

IL-27 induces an IFN-like signature in murine macrophages which in turn modulate colonic epithelium

D. Wink, H. Young, S. Durum, 2023, Frontiers in Immunology.

The chemical dynamics of NO and reactive nitrogen oxides: a practical guide.

D. Wink, L. Ridnour, N. Paolocci, 2004, Current molecular medicine.

Nitric oxide-induced resistance to hydrogen peroxide stress is a glutamate cysteine ligase activity-dependent process.

H. Forman, C. Hunt, L. Ridnour, 2005, Free radical biology & medicine.

Thiol-Activated HNO Release from a Ruthenium Antiangiogenesis Complex and HIF-1α Inhibition for Cancer Therapy

P. Sadler, D. Wink, L. Ridnour, 2016, ACS chemical biology.

Coexpression of NOS2 and COX2 accelerates tumor growth and reduces survival in estrogen receptor-negative breast cancer

J. Weiss, S. Lockett, S. Ambs, 2017, Proceedings of the National Academy of Sciences.

Dithiolethiones Inhibit NFk B Activity via Covalent Modi fi cation in Human Estrogen Receptor – Negative Breast Cancer

S. Ambs, A. Sparatore, D. Wink, 2012 .

Activation of matrix metalloproteinases following antiA b immunotherapy ; implications for microhemorrhage occurrence

C. Colton, D. Wilcock, D. Wink, 2015 .

Interferon-gamma is Quintessential for NOS2 and COX2 Expression in ER- Breast Tumors that Lead to Poor Outcome

S. Ambs, Jenny C. Chang, S. Hewitt, 2023, bioRxiv.

The Oncogenic Properties Of The Redox Inflammatory Protein Inducible Nitric Oxide Synthase In ER(-) Breast Cancer.

S. Ambs, D. Wink, L. Ridnour, 2015, Redox biology.

Interferon-gamma is quintessential for NOS2 and COX2 expression in ER- breast tumors that lead to poor outcome

S. Ambs, S. Hewitt, D. Wink, 2023, Cell death & disease.

Neuromedin B receptors regulate EGF receptor tyrosine phosphorylation in lung cancer cells.

G. Giaccone, T. Moody, D. Wink, 2010, European journal of pharmacology.

The emergence of nitroxyl (HNO) as a pharmacological agent.

D. Wink, C. Switzer, L. Ridnour, 2009, Biochimica et biophysica acta.

Chemotherapeutic potential of diazeniumdiolate-based aspirin prodrugs in breast cancer.

D. Wink, L. Ridnour, K. Miranda, 2014, Free radical biology & medicine.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Charles J. Vaske, Joe Y. Chang, Scott R. Presnell, 2016, Journal for ImmunoTherapy of Cancer.

Dithiolethiones inhibit NF-κB activity via covalent modification in human estrogen receptor-negative breast cancer.

S. Ambs, A. Sparatore, D. Wink, 2012, Cancer research.

Thrombospondin-1 and CD47 limit cell and tissue survival of radiation injury.

D. Wink, W. Degraff, L. Ridnour, 2008, The American journal of pathology.

The Chemical Biology of NO that Regulates Oncogenic Signaling and Metabolism: NOS2 and Its Role in Inflammatory Disease.

L. Ridnour, K. Miranda, D. Wink, 2023, Critical reviews in oncogenesis.

Adjuvant COX inhibition augments STING signaling and cytolytic T cell infiltration in irradiated 4T1 tumors.

D. Wink, L. Ridnour, S. Glynn, 2024, JCI insight.